title: Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand.
abstract: The significance of the maternal humoral immune response in relation to vertical transmission of HIV-1 was investigated in 123 mothers infected with subtype E from Thailand. Antibody binding titers to HIV-1 env domains (monomeric gp120, the CD4/gp120 binding site [BS], V3 loop, and gp41) and antibody-mediated neutralization of primary and T-cell line-adapted (TCLA) subtypes B and E HIV-1 isolates were investigated. No correlation between maternal anti HIV-1 antibodies at delivery and vertical transmission of HIV-1 subtype E was found. However, a trend to higher titer antibody-mediated cross-neutralization of a heterologous subtype B TCLA isolate, HIV-1MN, was observed in nontransmitting mothers postpartum. The HIV-1-specific antibody titers in these infected mothers increased significantly from delivery to 6 months postpartum (p < .05), but this was only partially attributable to hemodilution and an additional factor or factors appear to affect humoral immunity to HIV-1 during late pregnancy.
authors.affiliation: Department of Genito-Urinary Medicine and Communicable Diseases, Imperial College School of Medicine at St Mary's, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Louisirirotchanakul
authors.forename: S
authors.initials: S
authors.lastname: Beddows
authors.forename: R
authors.initials: R
authors.lastname: Cheingsong
authors.forename: N
authors.initials: N
authors.lastname: Shaffer
authors.forename: T D
authors.initials: TD
authors.lastname: Mastro
authors.forename: S
authors.initials: S
authors.lastname: Likanonsakul
authors.forename: C
authors.initials: C
authors.lastname: Wasi
authors.forename: G P
authors.initials: GP
authors.lastname: Taylor
authors.forename: J N
authors.initials: JN
authors.lastname: Weber
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D015331:Cohort Studies; D005260:Female; D015483:HIV Antibodies / Q000097:blood*; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000150:complications* / Q000276:immunology / Q000635:transmission*; D015497:HIV-1 / Q000145:classification* / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology*; D013785:Thailand
chemical_list: D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments